Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bioadhesion refers to the ability of a material (often a polymer, either natural or synthetic) to adhere to biological tissue via a variety of physicochemical mechanisms, including hydrogen bonding, electrostatic interactions, chain entanglement, mechanical interlocking, and macromolecular interpenetration[1][2][5][6][9]. The process can be subdivided by context: - *Type 1:* Adhesion between two biological substrates (e.g., cell-cell aggregation) - *Type 2:* Biological component adheres to an artificial substrate (e.g., cell culture plastics) - *Type 3:* Artificial material adheres to biological substrate (e.g., hydrogel or tissue glue on skin or mucosa)[1][2][5] Bioadhesion is especially important in drug delivery, where it enables formulations such as buccal, nasal, or ocular drug systems to remain in contact with tissue for extended durations[2]. It is not itself a protein, gene, or receptor, but a property arising from the interaction between materials and living surfaces[1][4][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bioadhesion.